mizing adverse effects has not been resolved. Previous reports and personal observations have shown that although lesions in the anterior aspect of the GPi improve dyskinesia, tremor is often unchanged. When the lesions are placed more posteriorly within the GPi, tremor is improved but dyskinesia is poorly controlled. 4, 8, 11, 12, 18, 21 Given this disparity of lesion effects, a combined approach might be expected to yield optimum control of both tremor and dyskinesia. The patients in the present study received two lesions within the posteroventral pallidum, but one was in the anterior aspect and one in the posterior aspect of the region. The incidence of complications remained low, and both tremor and dyskinesia were improved in most patients.
Another pressing issue surrounding pallidotomy is whether the size and placement of lesions correlates with patient outcome. Although previous reports have raised this issue, the question has not been wholly answered, in part because of discrepancies between the pre-and postoperative magnetic resonance (MR) images. In this study we analyzed the issue after the implementation of several technical changes: 1) after the pallidotomy, the frame was left on the patient's head and the patient was taken immediately for an MR study, which matched the study obtained prior to surgery; 2) targets were not obtained from a stereotactic atlas but from the patient's MR image, which allowed mapping to be performed for the area of interest only, rather than mapping the entire course of the needle track, thus minimizing the patient's time in the operating room; 3) the optic tract rather than the GP was used as the center of the stereotactic arc to ensure that the internal capsule was excluded from the probe track; and 4) the length of the needle track was minimized by creating the most direct route possible from the cortex to the target.
The 29 patients with recalcitrant Parkinson's disease discussed in this study received radiofrequency lesions placed in the medial aspect of the posteroventral pallidum (posteroventral medial pallidotomy) during the course of 1 year. Targeting for the procedure was guided by MR imaging and used microelectrode recording and stimulation for placement verification. Detailed analyses of performance changes in these patients 1 week and 3 months after surgery demonstrated significant improvement on most motor measures for all patients.
Clinical Material and Methods

Patient Population
Twenty-nine patients with Parkinson's disease who were responsive to levodopa treatment were selected for microelectrode-guided radiofrequency posteroventral medial pallidotomy in accordance with the patient selection criteria presented in Table 1 . Hoehn and Yahr staging for these patients was 1 to 3 while receiving medication and 3 to 4 while not receiving medication. The measures used to assess Parkinson's disease symptoms are described in Table 2 . The protocol and consent form for this study were approved by the Institutional Review Board of the Good Samaritan Hospital. All patients read and signed the consent form before entering the study.
After we determined that the selection criteria had been met, each patient entered a baseline evaluation phase that lasted 2 to 3 months. During this time, each individual underwent MR imaging and neurological and neurobehavioral assessments. Patients were evaluated both "on" and "off" medication as defined by the Core Assessment Program for Intracerebral Transplantation.
14 Each evaluation session was videotaped and scored in a blinded fashion. Postsurgical tests were performed at 2 to 7 days (hereafter referred to as 3 days) and 3 months after surgery. These included serial MR images, videotaped neurological examinations, and one complete cognitive evaluation at 3 months postsurgery.
Microelectrode Recording
For extracellular recording, commercially available electrolytically edged, pure iridium microelectrodes coated with 3 m parylene-C were used, yielding a tip impedance of 400 to 500 kohm at 1000 Hz. The length of exposed tip was 75 to 80 m (Micro Probe Inc., Clarksburg, MD). Extracellular recording was performed in consecutive order from the putamen, external GP (GPe), external segment of GPi (GPie), internal segment of GPi (GPii), ansa lenticularis, and the optic tract. The total length of the recorded microelectrode track was maintained at 20 mm, which minimized side effects and limited the duration of the procedure to between 2 and 2 1/2 hours. During recording, passive and active limb movements of wrist, elbow, shoulder, ankle, knee, and hip were studied and a somatotopic map was plotted along the microelectrode trajectories.
Extracellular action potentials were amplified by a factor of 10,000 with the microelectrode alternating current amplifier. The results were analyzed using commercially available software (SPIKE 2; Cambridge Electronic Design Ltd., Cambridge, UK). Firing rate/time and interspike and interburst interval histograms were analyzed. The optic tract was identified by strobe-evoked potentials visualized on the display of the oscilloscope and, more consistently, by characteristic audible signals from the audio monitor (model AM8; Grass Instruments, Quincy, MA). These findings were then confirmed by microstimulation applied to the optic tract via the exposed tip of the microelectrode. A stimulation current of 3 to 20 A at 200 Hz was generated by a stimulator (model S8800; Grass Instruments) and applied via photoelectric stimulus isolation 
Surgical Procedures
After the Leksell G stereotactic frame was applied to the patient's head using local anesthetic, MR images were obtained to localize the anterior and posterior commissure, the optic tract, the putamen, and the GP. All relevant images were transferred to the computer station and Leksell GammaPlan software (Elekta Instruments, Atlanta, GA) was used to determine the stereotactic coordinates. The magnetic field of the MR imaging apparatus was checked weekly to detect any distortion that may have affected targeting. Coordinates were referenced such that the optic tract (as the distal end of the electrode track) would be in the center of the stereotactic arc. Using actual MR images, the stereotactic coordinates were then determined for the radiofrequency lesions to be placed in the posteroventral region of the medial GPi. The trajectories for two microelectrode tracks were plotted: 1) 0 to 3 mm anterior and 21 to 26.5 mm lateral to the midcommissural point; and 2) 1 to 2 mm posterior and 19 to 25 mm lateral to the midcommissural point.
After appropriate coordinates were obtained, the patient was taken to the operating room and connected via the Leksell G-frame to the Mayfield adapter. The coordinates on the arc and coronal (15-30˚) and sagittal (2-15˚) angles were set, and the skin was anesthetized. A single burr hole approximately 2 cm in diameter was made to provide sufficient space to locate the two targets from which optimum control of the patients' symptoms could be achieved via microelectrode stimulation, as well as to avoid large cortical veins that might obstruct the planned site of needle entry. The dura was coagulated and opened in a cruciate fashion, and the pia was coagulated and penetrated by the guide tube with stylet (Radionics, Inc., Burlington, MA). The guide tube was positioned in the brain so that its tip was always 20 Ϯ 1 mm above the optic tract. A sterile microelectrode assembled with a 22-gauge guide tube in Teflon insulation was inserted into the first tube so that the exposed tip of the microelectrode was flush with both guide tubes. The proximal end of the microelectrode was then attached to the hydraulic microdrive mounted on the stereotactic arc instrument carrier in assembly with the x, y platform.
After the microelectrode entered the silent zone corresponding to the ansa lenticularis, the patient was exposed to a strobe light. The microelectrode was advanced until strobe-evoked potentials were visualized on the oscilloscope and identified by characteristic audible signals from the monitor. The recording mode was then changed to stimulation mode and the optic tract was stimulated (3-4 A at 200 Hz). Patients reported variable visual sensations (lines, spots, "stars" in different colors) in the contralateral visual field. Once the visual effect was achieved, the microelectrode was withdrawn until the visual response disappeared. If the internal capsule was located by its lack of cellular activity and characteristic tonic muscle contraction response, the probe was removed and replaced at a more lateral location to create a track that avoided the internal capsule. Such replacement was necessary in four of the 29 cases.
The depth of the microelectrode at which the visual response disappeared was determined as the lowest z coordinate of the prospective lesion. The upper z coordinate usually corresponded to the upper border of GPii identified on previous recordings. The proximal and distal z coordinates for each microelectrode pass were confirmed duration of peating timed tests after patient is off medication for at least 12 no significant change effect hrs pronation/supination on-con, on-ips, time required to perform 20 cycles of alternating tapping moveon-con, off-con: improvement, pϽ0.001; off-con, off-ips ments of the palm & dorsum of the hand on knee on-ips, off-ips: no significant change finger dexterity on-con, on-ips, time required for tapping the thumb w/ each finger in rapid succeson-con, off-con: improvement, pϽ0.001; off-con, off-ips sion for 10 repetitions on-ips, off-ips: no significant change foot tapping on-con, on-ips, no. of successive foot tapping movements performed in 60 sec on-con, off-con, on-ips: improvement, off-con, off-ips pϽ0.001; off-ips: no significant change ADL on/off rating scale for behaviors associated w/ normal daily activities improvement, pϽ0.001 (dressing, hygiene, writing) self-rating self-assessment scale of patient's condition improvement, pϽ0.001 by microstimulation (10-30 A, 5-100 Hz), which usually produced changes in tremor and/or muscle tone registered on the tremorgram and electromyogram. The microelectrode was then replaced by the lesion probe (diameter 1.1 mm, length of active tip 3 mm, GSK TM; Radionics, Inc.). The lesion probe was advanced to the lowest z coordinate and the stimulation was repeated (pulse duration 0.5 msec, frequency 100 Hz, stimulation ≤ 1.5 V). If visual response reappeared, the lesion probe was withdrawn by 500-m increments with repeated stimulations until no visual effects were obtained. At this point, the lesion was made using a lesion generator (RFG-JCC; Radionics, Inc.) at 80 to 85˚C for 85 seconds. The average height of the lesion was 5.6 mm.
Throughout the procedure, the patients' speech, motor, and visual functions were tested. The operation required approximately 2 to 2 1/2 hours. Immediately after the procedure a second MR image was obtained with the stereotactic frame in place for the postoperative analysis of the lesion location. Decadron (10 mg) was administered to minimize postoperative edema.
Statistical Analysis
Analyses were conducted in a hierarchical manner to minimize the possibility of type I errors. The effect of the surgical procedure was analyzed for each dependent variable using a repeated-measures analysis of variance (ANOVA) for three occasions (baseline, 3 days postsurgery, 3 months postsurgery). Given a significant overall ANOVA effect (p Ͻ 0.05), post hoc two-tailed t-tests for matched samples were conducted for the following time periods: 1) baseline versus 3 days postsurgery, 2) baseline versus 3 months postsurgery; and 3) 3 days versus 3 months postsurgery.
Results
Microelectrode Recordings From the GP
Extracellular recording from the external GPe exhibited individual low-frequency and low-voltage spikes (Fig.  1A) . The spike width was measured as approximately 1.16 msec. When the probe passed into the GPie, individual spikes of high frequency and voltage were recorded, interspersed with bursts of activity (Fig. 1B) . Occasionally characteristic high-frequency, low-voltage bursts were also observed in the GPie. In the GPii the spikes displayed the highest frequency and voltage, with a spike width of 1.2 msec (Fig. 1C) .
Postoperative Effects of Pallidotomy
The placement of the needle track and anterior and posterior lesions in a representative case are depicted in Fig.  2 . The MR images of pallidotomy location revealed small lesions placed within the GPi (Fig. 3) . Four patients displayed transitory facial asymmetry that lasted between 3 days and 2 weeks. Several measures of symptom severity for Parkinson's disease confirmed statistically significant improvement at both the 3-day and the 3-month postoperative timepoints (Table 3) . These measures included Unified Parkinson's Disease Rating Scale (UPDRS) scores (Fig. 4A) ; Hoehn and Yahr scores (Fig. 4B) ; dyskinesia intensity and duration (Fig. 4C) ; dystonia, gait freezing, and rigidity (Fig. 4D) ; tremor (Fig. 5A) ; handwriting (Fig. 5B) ; activities of daily living (ADL) (Fig.  5C) ; and patient self-rating (Fig. 5D ). Two weeks after posteroventral medial pallidotomy, 19 patients (65.5%) no longer displayed tremor, six (20.7%) displayed minimal tremor, and four (13.8%) displayed a noticeable tremor that did not interfere with movement. When patients were examined 3 months postsurgery, the numbers had changed to 26 (89.7%) with no tremor, two (6.9%) with minimal tremor, and one (3.4%) with noticeable tremor. In patients who underwent posteroventral medial pallidotomy in the hemisphere contralateral to their dominant hand, the size and clarity of handwriting were also improved in both medication states (Fig. 5B) . Patients exhibited an improvement in onset in the singledose levodopa test, although the duration of effects did not change after posteroventral medial pallidotomy (Fig. 5E ).
The number of hours spent in the "off" state per day was also significantly decreased both 1 day and 3 months postsurgery (Fig. 5F ).
Patients exhibited some variability of performance on the timed dexterity tests, yet all showed improvement on the side contralateral to the surgery regardless of medication state (Fig. 6 and Table 3 ). There were no significant differences between performances at 3 days and 3 months postoperatively on any of these timed tests. Pronation and supination of the forearm were significantly improved on the side contralateral to the posteroventral medial pallidotomy; however, ipsilateral side performance was not significantly improved in either medication state (Fig.  6A) . Finger dexterity was improved on both the contralateral and the ipsilateral side, and this improvement persisted while patients were not receiving medication (Fig. 6B) . Foot tapping was significantly improved on the contralateral side both on and off medication, whereas performance on the ipsilateral side was significantly improved only while patients were receiving medication (Fig. 6C) .
Discussion
This study examined the impact of pallidotomy targeted at the medial aspect of the posteroventral pallidum in 29 patients with Parkinson's disease. Significant improvements in patients' capabilities were observed 1 day postoperatively and persisted at the 3-month follow-up review. Four patients experienced transitory facial asymmetry following the surgery, but by the 3-month follow-up examination no patient exhibited signs of side effects. Hoehn and Yahr and UPDRS scores decreased significantly while patients were both on and off medication, as did dyskinesia intensity and duration, and ADL, rigidity, dystonia, tremor, and self-rating scores all showed improvement. Patients' ability to perform the stand, walk, and sit test was also significantly improved both on and off medication, and their hours of not receiving medication each day were decreased. Dexterity tests for finger movements were improved on both sides while patients were on medication. Dexterity in the side contralateral to the posteroventral medial pallidotomy was also improved while patients were off medication. Pronation/supination and foot tapping were both improved on the contralateral side while patients were on medication.
During the course of the pallidotomy procedure, extracellular recordings were obtained from the GP. The extracellular recordings provided clear and accurate information on points of entry and exit of the GP, with a resolution of approximately 100 m, rendering single-unit recording unnecessary. Spontaneous activity profiles recorded in three regions of the GP (the GPe, GPie, and GPii) corresponded with readings obtained in these regions in other studies. 6, 17, 19 The GP has been described as having a rough somatotopy. 17 Further advancement in recording capabilities and lesion accuracy may allow use of this somatotopy to achieve the same positive pallidotomy results with a smaller lesion area.
Although early pallidotomies were performed in the anterodorsal pallidum, 4, 8, 18 later studies have revealed that lesions of the posteroventral pallidum yielded superior control of bradykinesia and tremor. 13, 21 The posteroventral lesion location has since been targeted in a large number 2, [10] [11] [12] [13] [15] [16] [17] 20 Even within the posteroventral pallidum, however, subtle differences in lesion targeting have the potential to affect outcome. Our study has further refined the pallidotomy target area by focusing on the medial aspect within the posteroventral pallidum and by combining the effects of two lesions within this area, one anterior and one posterior to the midcommissural point. The improvements in motor function exhibited by most patients following such pallidotomies agree with those found in previous reports using posteroventral pallidotomy, but include greater tremor control than previously shown. These results provide evidence that a lesion of this subregion of the GPii is effective in controlling symptoms of Parkinson's disease.
The effects of posteroventral pallidotomy on tremor appear to be more inconsistent than its effects on other motor symptoms; tremor is improved in only a fraction of patients who undergo pallidotomy. strated a significant decrease in tremor 2 weeks after posteroventral medial pallidotomy, and this percentage had increased by 3 months postoperatively. The reasons for this continuing improvement are unclear, although the interrupted striatocortical pathways may have continued to compensate for the lesion over time, possibly leading to more effective connectivity within the motor circuit. Further research into changes in striatal connectivity in the brains of patients with Parkinson's disease and the ways in which pallidotomy exerts its ameliorative influence may provide further insight into development or decline of the effects of pallidotomy with time.
Although the patients undergoing posteroventral medial pallidotomy demonstrate significant tremor improvement overall, some individual variability in tremor effects does persist. This variability may be attributable to differences in lesion location or size. Because MR images were obtained immediately before and immediately after posteroventral medial pallidotomy without removal of the frame, it is possible to compare images to determine the lesion location and size. Postoperative changes can then be examined in light of these data to investigate whether there is a significant correlation. A detailed analysis of lesion size and location is in progress to provide further insight into the neural substrates of Parkinson's disease symptoms, as well as the optimum location for pallidotomy lesions.
None of the patients in the present study displayed lasting adverse effects from the procedure, although four patients did exhibit transitory facial asymmetry immediately postoperatively. A lesion of an effective size for pallidotomy leads to edema that may affect a larger region than the target area. In some patients, this perilesional edema can spread to the optic tract or internal capsule, causing side effects that resolve as the swelling subsides. Permanent adverse side effects of pallidotomy have been minimized by means of technical refinements, particularly the use of MR imaging guidance, as well as microelectrode recording and stimulation prior to formation of the lesion.
Microelectrode-guided radiofrequency pallidotomy is becoming a well-characterized procedure for treatment of Parkinson's disease. Its most consistent and marked ef-fects are on dyskinesia, tremor, rigidity, and bradykinesia, which contribute to improved ADL and self-rating scores. In the current study we have further investigated the treatment potential of pallidotomy by using a medial target in the posteroventral pallidotomy and by presenting the results for a large group of patients receiving treatment in a circumscribed time frame. Future studies will use these methodologies to identify the most efficacious lesion site in the GPi and elucidate the neural mechanisms underlying Parkinson's disease.
